These miRNAs effectively inhibited αvβ3 integrin-dependent FAK activation and restored sensitivity to the HSP90 inhibitor AUY922 in the KRAS-mutated NSCLC cell lines A549 and H1944 [137]. The gene discussed is PTK2; the disease is non-small cell lung carcinoma.